Status:
COMPLETED
Treatment of Fibromyalgia Using Deep Shaped-Field Transcranial Magnetic Stimulation a Clinical Feasibility Study
Lead Sponsor:
Cervel Neurotech, Inc.
Conditions:
Fibromyalgia
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Deep shaped-field transcranial magnetic stimulation is a new type of transcranial magnetic stimulation technology which may provide a drug-free method for treating fibromyalgia. The purpose of this s...
Eligibility Criteria
Inclusion
- Fibromyalgia as diagnosed by American College of Rheumatology (ACR) criteria.
- Moderate or severe pain from fibromyalgia despite current treatment regimen.
- Will not become pregnant during study.
Exclusion
- Seizure disorder.
- Metal implants on or in brain, spinal cord, ear, eye or heart.
- Current use of proconvulsant medications (e.g., bupropion).
- Taking oral amitriptyline \> 100 mg once daily at bedtime.
- Nonscheduled analgesic, anticonvulsant or antidepressant medications.
- Severe depression or suicidality.
- Other significant psychiatric disorder.
- Previous use of TMS.
Key Trial Info
Start Date :
August 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT01229852
Start Date
August 1 2010
End Date
October 1 2011
Last Update
May 19 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Premier Research Group
Phoenix, Arizona, United States, 85381